Nitazoxanide in the treatment of amoebiasis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 10, 2007, Pages 1025-1031

  Rossignol, Jean François ^a   Kabil, Samir M ^b   El Gohary, Yehia ^c   Younis, Azza M ^d  

^a Romark Institute for Medical Research   (United States)

^b BENHA UNIVERSITY   (Egypt)

^c ALEXANDRIA UNIVERSITY   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

Amoebiasis; Anti infective agents; Entamoeba histolytica; Nitazoxanide; Parasitic diseases; Treatment

Indexed keywords

NITAZOXANIDE; PLACEBO;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGE DISTRIBUTION; AMEBIASIS; ARTICLE; BACTERIAL COLONIZATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DYSPEPSIA; EGYPT; ENTAMOEBA HISTOLYTICA; FATIGUE; FECES ANALYSIS; FEMALE; HEPATITIS; HOSPITALIZATION; HUMAN; INTESTINE FLORA; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTPATIENT CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; URINE COLOR; VOMITING;

ADOLESCENT; ADULT; AMEBICIDES; ANIMALS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DYSENTERY, AMEBIC; ENTAMOEBA HISTOLYTICA; FEMALE; HUMANS; INFANT; LIVER DISEASES, PARASITIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THIAZOLES; TREATMENT OUTCOME;

ENTAMOEBA HISTOLYTICA;

EID: 34548279910     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2007.04.001     Document Type: Article

References (18)

1. Adagu I.S., Nolder D., Warhurst D.C., and Rossignol J.F. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. 49 (2002) 103-111
2. Amadi B., Mwiya M., Musuku J., Watuka A., Sianongo S., Ayoub A., and Kelly P. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 360 (2002) 1375-1380
3. Anonymous, 2004. Drugs for Parasitic Infections. The Medical Letter on Drugs and Therapeutics. http://www.medicalletter.org [accessed 29 March 2007].
4. Cooperstock M., DuPont H.L., Corrado M.L., Fekety R., and Murray D.M. Evaluation of new anti-infective drugs for the treatment of diarrhea caused by Entamoeba histolytica. Clin. Infect. Dis. 15 Suppl. 1 (1992) S254-S258
5. Fox L.M., and Saravolatz L.D. Nitazoxanide: a new thiazolide antiparasitic agent. Clin. Infect. Dis. 40 (2005) 1173-1180
6. Haque R., Huston C.D., Hughes M., Houpt E., and Petri Jr. W.A. Amebiasis. N. Engl. J. Med. 348 (2003) 1565-1573
7. Musher D.M., Logan N., Hamill R.J., DuPont H.L., Lentnek A., Gupta A., and Rossignol J.F. Nitazoxanide in the treatment of Clostridium difficile colitis. Clin. Infect. Dis. 43 (2006) 421-427
8. Ortiz J.J., Ayoub A., Gargala G., Chegne N.L., and Favennec L. Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis from Northern Peru. Aliment. Pharmacol. Ther. 15 (2001) 1409-1415
9. Pankuch G.A., and Appelbaum P.C. Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic bacteria. Antimicrob. Agents Chemother. 50 (2006) 1112-1117
10. Petri Jr, W.A., Singh, U., Ravdin, J.I., 1999. Enteric amebiasis, in: Guerrant, R.L., Walker, D.H., Weller, P.F. (Eds), Tropical Infectious Diseases: principles, pathogens & practice, Vol. 1. Churchill Livingstone, Philadelphia, PA, pp. 685-702.
11. Rossignol J.F., and El-Gohary Y. Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo controlled clinical trial. Aliment. Pharmacol. Ther. 24 (2006) 1423-1430
12. Rossignol J.F., Ayoub A., and Ayers M.S. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a double blind placebo controlled study of nitazoxanide. J. Infect. Dis. 184 (2001) 381-384
13. Rossignol J.F., Kabil S.M., Said M., Samir H., and Younis A. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin. Gastroenterol. Hepatol. 3 (2005) 987-991
14. Rossignol J.F., Abu-Zekry M., Hussein A., and Santoro M.G. Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial. Lancet 368 (2006) 124-129
15. Rossignol, J.F., Korba, B.E., Kabil, S.M., 2006b. Nitazoxanide in treating chronic hepatitis B: in vitro activity and clinical case reports, in: Digestive Disease Week; 20-25 May 2006; Los Angeles, CA.
16. Rossignol, J.F., Korba, B.E., Kabil, S.M., 2006c. Nitazoxanide in treating chronic hepatitis C: in vitro activity and a clinical case series, in: Digestive Disease Week; 20-25 May 2006; Los Angeles, CA.
17. Rossignol J.F., Kabil S.M., El-Gohary Y., and Younis A.M. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium spp. Clin. Gastroenterol. Hepatol. 4 (2006) 320-324
18. Tanyuksel M., and Petri Jr. W.A. Laboratory diagnosis of amebiasis. Clin. Microbiol. Rev. 16 (2003) 713-729